S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
66,000% upside on tiny biotech? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
OTCMKTS:NROM

Noble Roman's (NROM) Stock Forecast, Price & News

$0.27
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
$0.27
$0.27
50-Day Range
$0.26
$0.35
52-Week Range
$0.17
$0.42
Volume
N/A
Average Volume
6,029 shs
Market Capitalization
$6.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NROM stock logo

About Noble Roman's (OTCMKTS:NROM) Stock

Noble Roman's, Inc. engages in the business of selling and providing services franchises and licenses and operating company-owned stand-alone restaurants and non-traditional foodservice operations. The company was founded in 1972 and is headquartered in Indianapolis, IN.

Receive NROM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Noble Roman's and its competitors with MarketBeat's FREE daily newsletter.

NROM Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Roman Forum
Alison Roman Won't Sugarcoat It
NROM Noble Roman's, Inc.
See More Headlines

NROM Price History

NROM Company Calendar

Last Earnings
3/31/2023
Today
6/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Eating places
Sub-Industry
N/A
Current Symbol
OTCMKTS:NROM
Employees
44
Year Founded
N/A

Profitability

Net Income
$-1,060,000.00
Pretax Margin
0.83%

Debt

Sales & Book Value

Annual Sales
$14.45 million
Book Value
$0.12 per share

Miscellaneous

Free Float
15,529,000
Market Cap
$6.00 million
Optionable
Not Optionable
Beta
1.03

Key Executives

  • Paul W. Mobley
    Executive Chairman, Chief Financial Officer & PAO
  • A. Scott Mobley
    President, CEO, Secretary & Director
  • Terry Farabaugh
    Operations Director
  • Troy Branson
    Executive Vice President-Franchising
  • Michael Lingor
    Vice President-Franchise Development













NROM Stock - Frequently Asked Questions

How have NROM shares performed in 2023?

Noble Roman's' stock was trading at $0.2675 at the beginning of the year. Since then, NROM stock has increased by 0.9% and is now trading at $0.27.
View the best growth stocks for 2023 here
.

How were Noble Roman's' earnings last quarter?

Noble Roman's, Inc. (OTCMKTS:NROM) issued its quarterly earnings data on Friday, March, 31st. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $4.16 million for the quarter. Noble Roman's had a negative net margin of 7.05% and a negative trailing twelve-month return on equity of 42.40%.

What other stocks do shareholders of Noble Roman's own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Noble Roman's investors own include IntelGenx Technologies (IGXT), Inpixon (INPX), Aware (AWRE), Bridgeline Digital (BLIN), ENGlobal (ENG), InterCloud Systems (ICLD), PositiveID (PSID), Synacor (SYNC), ARCA biopharma (ABIO) and Acorn Energy (ACFN).

What is Noble Roman's' stock symbol?

Noble Roman's trades on the OTCMKTS under the ticker symbol "NROM."

How do I buy shares of Noble Roman's?

Shares of NROM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Noble Roman's' stock price today?

One share of NROM stock can currently be purchased for approximately $0.27.

How much money does Noble Roman's make?

Noble Roman's (OTCMKTS:NROM) has a market capitalization of $6.00 million and generates $14.45 million in revenue each year. The company earns $-1,060,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis.

How can I contact Noble Roman's?

Noble Roman's' mailing address is 6612 E. 75th Street Suite 450, Indianapolis IN, 46250. The official website for the company is www.nobleromans.com. The company can be reached via phone at (317) 634-3377, via email at pmobley@nobleromans.com, or via fax at 317-636-3207.

This page (OTCMKTS:NROM) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -